Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 480-240-4 | CAS number: 185257-07-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
oral
rat: LD50 >25 <200 mg/kg bw , no signs of toxicity (GLP, comp. OECD 423; BASF AG 1997)
dermal
rat: LD50 > 2000 mg/kg bw (GLP, OECD 402; BASF AG 2006)
inhalation
no data available
Key value for chemical safety assessment
Additional information
There are reliable data available to assess the acute oral and dermal toxicity of the test substance.
oral
A GLP conform study was performed to assess the acute toxicity following oral administration of MGDN (purity: 97.9%) in Wistar rats comparable to the acute toxic class method described in OECD guideline 423 (based on EEC guideline 92/69, B.1; BASF AG 1997).
To a group of six fasted animals (three males and three females) a single oral dose of the test material preparation in Tylose CB 30.000, 0.5%in aqua bidest.. At a dose level of 25 mg/kg body weight was given. Another group of three male rats was treated in the same way with a dose of 200 mg/kg body weight. In both treatments, the dose volume was 10 mL/kg body weight.
Signs of toxicity noted in the 200 mg/kg dose group were poor general state, dyspnoea, apathy, ataxia, tremor, twitching and salivation. The animals of the 25 mg/kg dose group did not show any symptoms.
The expected body weight gain was observed in the course of the study.
All animals of the 200 mg/kg dose group died within 2 hours after application. Necropsy finding of the animals that died was agonal congestion. No abnormalities were noted at necropsy of animals sacrificed at the end of the study.
Under the conditions of this study the median lethal dose of MGDN after oral application was found to be greater than 25 mg/kg and less or equal 200 mg/kg body weight.
dermal
The GLP conform study was performed to assess the acute dermal toxicity of MGDN in Wistar rats and followed OECD guideline 402 (BASF AG 2006). A single dose of 2000 mg/kg body weight of a test material preparation (purity: 99.5 area-%; dose volume 2.86 g/kg bw) in 0.5% CMC-solution in doubly distilled water was applied in five male and five female animals to ca. 10% of the clipped skin (dorsal and dorsolateral parts of the trunk) and covered by a semi-occlusive dressing for 24 hours.
No mortality occurred. No systemic clinical observations or skin effects were noted in the animals. The mean body weights of the animals increased throughout the study period. No macroscopic pathologic abnormalities were noted in the animals examined at the end of the study.
Under the conditions of this study, the acute dermal median lethal dose (LD50) of MGDN after dermal application was found to be greater than 2000 mg/kg body weight in male and female rats.
inhalation
no data available
Justification for classification or non-classification
oral
Based on the available data, the oral LD50 is > 25 and <200 mg/kg bw in rats. Therefore, MGDN has to be considered as toxic if swallowed and has to be classified with R25 according to 67/548/EEC. Regarding the complete absence of signs of toxicity at 25 mg/kg bw, it is assumed that the LD50 level is > 50 mg/kg bw. Therefore, Cat. 3 is warranted according to EU-GHS and OECD-GHS, respectively.
dermal
Based on the available data, the dermal LD50 is > 2000 mg/kg bw in rats. No signs were observed at this level. Therefore, no indication is given for classification according to 67/548/EEC, EU-GHS and OECD-GHS, respectively.
inhalation
No data available.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.